HIF1A and cancer: Thanks to its ability to reduce angiogenesis by blocking VEGFA and HIF1α in IH, its high potential for use in cancer therapy is clearly indicated, since hypoxia and subsequent activation of the expression of HIF-dependent proteins play a vital role in cancer progression.